Telomeres may regulate human disease by at least two independent mechanisms. First, replicative senescence occurs once short telomeres generate DNA-damage signals that produce a barrier to tumor progression. Second, telomere position effects (TPE) could change gene expression at intermediate telomere lengths in cultured human cells. Here we report that telomere length may contribute to the pathogenesis of facioscapulohumeral muscular dystrophy (FSHD). FSHD is a late-onset disease genetically residing only 25-60 kilobases from the end of chromosome 4q. We used a floxable telomerase to generate isogenic clones with different telomere lengths from affected patients and their unaffected siblings. DUX4, the primary candidate for FSHD pathogenesis, is upregulated over ten-fold in FSHD myoblasts and myotubes with short telomeres, and its expression is inversely proportional to telomere length. FSHD may be the first known human disease in which TPE contributes to age-related phenotype.
Facioscapulohumeral muscular dystrophy (FSHD1A, MIM 158900) is one of the most prevalent myopathies, affecting approximately 1 in 20,000 individuals [1] [2] [3] [4] . It is genetically linked to a reduced number of tandemly repeated 3.3-kilobase (kb) D4Z4 elements present near the telomere of chromosome 4q. Unaffected individuals have up to 100 repeats, whereas only 1-10 repeats are present in patients with FSHD 5, 6 . The disease has a highly variable clinical expression of progressive atrophy and weakness of the facial, scapular and upperarm muscles (hence the name) and has the unusual characteristic of myopathies of delayed appearance, in which symptoms often do not appear until the second or third decade of life or later 7 . The disease requires the presence of additional genetic markers on both sides of the repeats (Fig. 1a) .
The current leading candidate for mediating pathogenesis in FSHD is the DUX4 homeobox protein in the final D4Z4 repeat [8] [9] [10] . The long but not the short form of DUX4 is toxic when overexpressed [11] [12] [13] , though toxicity of endogenous DUX4 has not yet been demonstrated. It has become increasingly clear that there are additional factors contributing to the pathogenesis of FSHD. Although FSHD has traditionally been considered to be an autosomal dominant disease, the prevalence of its genetic signature (a reduced number of D4Z4 repeats on chromosome 4 in combination with the 4A161PAS haplotype) is present in ~1% of the general population 14 , roughly two orders of magnitude higher than the incidence of the disease. Moreover, DUX4 full-length (DUX4-fl) mRNA and protein is expressed in some unaffected subjects without D4Z4 deletions 15 . This suggests that other unknown factors are important.
Telomere shortening has primarily been investigated as a tumorsuppression mechanism. It limits the number of available divisions before some telomeres become sufficiently short to induce a signal from nonrepairable DNA damage. This causes growth arrest and prevents premalignant cells from continuing to accumulate the changes needed to form progressive tumors 16 . A second function of telomere shortening that has received relatively little attention is its potential for regulation of gene expression by trapping adjacent genes in heterochromatin, a phenomenon known as TPE 17 .
There is no explanation for the delayed onset of FSHD. There has been speculation about position-effect variegation, the term derived from the Drosophila melanogaster literature to describe the repression of genes by adjacent heterochromatin 18 . TPE describes the special case of position-effect variegation that occurs for genes located near telomeres. TPE, originally described in D. melanogaster and Saccharomyces cerevisiae 19, 20 , exists in mammalian cells expressing artificially produced reporter constructs [21] [22] [23] [24] . A single endogenous human gene located 1 megabase from the end of chromosome 1p, ISG15, has been found to be regulated by telomere length 25 . Because many genes distal to ISG15 are not regulated by telomere length, it does not conform to classical TPE in which repression extends in a continuously decreasing a r t i c l e s fashion from the telomeres. ISG15 is involved in innate immunity, and although it is an attractive candidate for contributing to an increased inflammatory response in aging ('inflammaging'), it has so many inputs driving its expression that it would be difficult to establish that telomere shortening is an important contributor.
The presence of the FSHD locus adjacent to the end of chromosome 4q raises the possibility that >300 kb of D4Z4 repeats functions as an insulator 26, 27 and repressor 26 that blocks both the expression of DUX4 (repressor function) and the spreading of telomeric heterochromatin (insulator function) in unaffected individuals. The loss of these activities in contracted alleles would then permit telomere shortening to regulate the expression of internal genes. This could explain the age-associated manifestation of symptoms, because significant shortening might be required before genes such as DUX4 are upregulated ( Fig. 1b) . To answer the question of whether telomere shortening influenced the expression of subtelomeric genes, we first obtained muscle samples from both patients with FSHD and their unaffected family members. We then immortalized myoblasts by using a floxable telomerase (TERT) cDNA 28 , isolated individual clones, excised TERT at different times and examined the effects of telomere shortening on gene expression in isogenic cell lines in the absence of confounding factors. We demonstrate that DUX4-fl expression is upregulated by telomere shortening in cells from FSHD-affected subjects, in some cases by 100-fold between cells with long and short telomeres. The effect is progressive with decreasing telomere length and occurs long before terminal telomere shortening would induce replicative senescence. The targets of DUX4 expression are also upregulated as a consequence of the TPE-induced increased expression of DUX4. The effect of TPE is most prominent with DUX4, the gene nearest the telomere. The effect of TPE is present but less prominent in FRG2, which is approximately 70 kb more internal compared to DUX4, and is not observed with FRG1, which is an additional 90 kb from the telomere (Fig. 1a) . TPE in FSHD thus follows the classical model of continuous heterochromatin spreading that declines with distance from the telomere.
RESULTS

Generating clonal cell lines with long and short telomeres
Primary cultures are heterogeneous in terms of both cell types and telomere lengths within a particular cell type. To experimentally isolate the effects of telomere length from other confounding factors, we first isolated clones and then produced isogenic subclones with different telomere lengths by using a floxable TERT. Cells were obtained from two family cohorts (01 and 15) with affected and unaffected family members 28, 29 . One additional FSHD strain (GM17731) and one myopathy control (merosin-deficient congenital muscular dystrophy, MDC1A, 38/03) were included. Multiple isogenic subclones were derived from 12 lines (for example, deltoid and biceps from one individual equals two lines) described in Supplementary npg a r t i c l e s unaffected sibling controls and one from the MDC1A control myopathy. Notably, we controlled for family effects 29 by comparing FSHD lines to lines from unaffected siblings ( Supplementary Table 1 : for example, lines 15Vbic and 15Vdel are derived from biceps and deltoid of the unaffected sister of FSHD-affected subjects 15A and 15B, both of whom have a contracted D4Z4 allele). Primary muscle cultures transduced with CDK4 (to circumvent growth arrest due to inadequate culture conditions 30 (Fig. 1c) , thus enabling the isolation of myogenic clones) were reversibly immortalized with a floxable TERT 28 . Excision of TERT by Cre recombinase 1 week after TERT introduction yielded subclones with slightly elongated telomeres and extended lifespan ( Fig. 1d , 15Abic subclone 1 (orange line) compared with the parental CDK4 clone (black line); Supplementary  Fig. 1 shows other clones). In vitro propagation produced shortened telomeres (for example, subclone 1 of 15Abic in Fig. 1e and other clones in Supplementary Fig. 1 ). An isogenic subclone with long telomeres was generated by excising TERT ~60 population doublings (PDs) after its introduction (for example, subclone 2 in Fig. 1d,e ). All clones and subclones were tested for efficient fusion into multinucleated myotubes when switched to differentiation medium. Clones with short telomeres were used before the end of their logarithmic growth phase, well before the onset of replicative senescence.
DUX4 and FRG2 are induced in FSHD with short telomeres
Several genes have been reported as dysregulated in FSHD, including the current primary candidate DUX4 (refs. 8,13), FRG2, FRG1 and SLC25A4 (refs. 31, 32) . We investigated the effects of telomere length on transcription of these genes by measuring their mRNA levels by using quantitative real-time PCR (qrt-PCR). Figure 2 shows representative results for the three genes closest to the 4q telomere (DUX4, FRG2 and FRG1; Fig. 1a shows genomic locations) in isogenic subclones with long (light colors) or short telomeres (dark colors), derived from two brothers with a shortened FSHD locus (15A and 15B) and their unaffected sister without a D4Z4 contraction (15V). Data from independent repetitions are combined in Supplementary Figure 2a ,b. Subclones from unaffected 15V did not express detectable DUX4 under any condition, as expected from their nonpermissive genotype (4qB/4qB and missing the poly(A) signal that stabilizes DUX4 transcripts) 15 . We found that most cycling FSHD subclones with long telomeres had DUX4 levels five ; second bar represents day 7 in differentiation medium). Samples with Cp values equal to or more than that of a water-only control are designated '0' to indicate the absence of detectable transcripts under these RT-PCR conditions. FRG2 RT-PCR was optimized to specifically detect transcripts from chromosome 4q ( Supplementary Fig. 3b ). Shown are mean Cp values ± s.d. of three technical replicates of a representative experiment; each subclone was independently analyzed two to five times, and all values are shown in Supplementary Figure 2a ,b. The y axis is plotted as decreasing values, so that an increase in mRNA appears as a taller bar. Each Cp value represents a doubling of the input, so the difference between (for example) 15 and 20 represents a 2 5 = 32-fold difference. npg a r t i c l e s crossing-point (Cp) values (~30 fold) above the qrt-PCR detection limit that increased 4-1,000 fold upon telomere shortening. Differentiation increased DUX4 levels as reported 15 . Short telomeres augmented this increase. Subclones 15Abic, 15Bbic and 15Bdel showed a difference of ~8 Cp (~250 fold increased expression) between short and long telomeres. The 15Adel subclone exhibited a smaller increase (3-4 Cp, ~10-20 fold). DUX4 detection rates were significantly higher in samples with shortened versus normal D4Z4 loci (P = 1.2 × 10 -4 ), in samples with short versus long telomeres (P = 9.9 × 10 −11 ) and in differentiated versus cycling cells (P = 1.1 × 10 −3 by likelihood-ratio test for binomial mixed-effect models). FRG2 was similarly regulated by both differentiation and telomere length in FSHD cells. Although expressed by cells without D4Z4 contractions (15Vbic and 15Vdel), these controls showed no induction by differentiation or telomere shortening. FRG1 levels were constant under all conditions tested, as were other more centromeric genes at 4q (LRP2BP, PDLIM3 and SLC25A4; data not shown). We confirmed that all subclones, whether with FSHD or control or with long or short telomeres, had similar expression profiles of several skeletal muscle differentiation markers ( Supplementary Fig. 3a) .
We confirmed the generality of these results in six additional subclones from three FSHD lines and five additional subclones from three control lines ( Supplementary Fig. 2c-f) . We found increased expression of both DUX4 and FRG2 in both subclones of FSHD line 01Adel, in one in three subclones from FSHD line 01Abic and in the subclone from FSHD line GM17731. We observed DUX4 in two subclones from unaffected subject 01Ubic and in one from 01Udel, and we also saw it slightly upregulated in cells with short telomeres. Notably, we did not detect DUX4 in cells from an unrelated myopathy but did find that FRG2 levels were similar to those in cells from unaffected donors and were marginally regulated by telomere length (Supplementary Fig. 2c) .
In summary, we demonstrated that the two genes closest to the telomere at chromosome 4q, but not more centromeric genes, are regulated by telomere length, specifically in cells with contracted D4Z4 repeats.
DUX4 expression is inversely proportional to telomere length
The general outline of our approach to generate samples from an FSHD clone (01Adel) with a wide range of telomere lengths ( Fig. 3a) and the corresponding growth curves (Fig. 3b ) are shown. We treated the Lox-TERT-expressing clone (red line) with Cre recombinase at various times to produce subclones of different telomere lengths and time in culture. We obtained subclone 1 with ~20-kb telomeres (point A in Fig. 3b ) by excising Lox-TERT after 37 PDs (Fig. 3a) . We then cultured these cells and harvested samples at multiple time points (B-G in Fig. 3b ). We excised TERT after 180 PDs to yield subclone 2, which had ~24-kb telomeres at the time of analysis at PD 216 ( Fig. 3a,b) . We analyzed telomere length and DUX4 and FRG2 mRNA levels for all samples. We found a linear correlation between telomere length and DUX4 Cp values for cycling and differentiating myoblasts, with correlation coefficients of 0.93-0.96 ( Fig. 3c) . We showed that the continuous increase in DUX4 expression in subclone 1 is not simply due to accumulating PDs, because subclone 2 with ~24-kb telomeres exhibited the lowest level of DUX4 at the same PD at which subclone 1 had the highest (PD 216, samples A and H in Fig. 3b,c) . We also found that FRG2 expression inversely correlated with telomere length, although the correlation was weaker (correlation coefficient 0.7 for differentiating cells; Supplementary Fig. 4 ).
DUX4 and FRG2 regulation by telomere length is direct
Transiently transfected reporter constructs containing the DUX4 or FRG2 promoter fused to luciferase 9, 33 should respond if DUX4 and FRG2 upregulation in cells with short telomeres is regulated in trans rather than directly by the adjacent telomere. However, we found that both promoter constructs were equally active in cells with long or short telomeres ( Fig. 4) . We demonstrated that these reporter constructs could effectively respond to trans-acting regulatory factors, as they were induced during differentiation similarly to the endogenous genes at their native telomeric position ( Fig. 4) .
DUX4 induction by telomere shortening induces DUX4 targets
DUX4-fl has two N-terminal homeodomains 34 that mediate sequencespecific DNA binding and a C-terminal transactivation domain 35 . A cryptic splice site can remove the C-terminal domain, producing the shorter splicing isoform DUX4-s 13 that has dominant-negative activity following overexpression 36 . DUX4-fl, but not DUX4-s, is thought to cause or at least contribute to FSHD 13 . The DUX4 data ( Figs. 2 and 3 ) did not distinguish between DUX4 splice variants. The level of DUX4 is far too low to observe by Northern analysis, requiring ~50 cycles of nested RT-PCR to detect. We consistently detected DUX4-fl in our clonal lines by using RT-PCR (Fig. 5a) . We barely detected DUX4-s (representative subclone 01Adel in Fig. 5a ). In agreement with the qrt-PCR results, stronger signals were observed in samples from cells with short telomeres compared to cells with long telomeres. We verified all PCR products as chromosome 4q DUX4 transcripts by sequencing.
DUX4 activated its target genes in these cells. We observed increased transcription from two targets (ZSCAN4 and KHDC1) 36 . (The samples in Fig. 2 are shown in Fig. 5b , and eight additional targets are shown in Supplementary Fig. 5a.) Overall, we showed that DUX4 target-gene expression correlated with DUX4 expression. Target genes were expressed at low abundance in cycling cells, with a trend of being higher both in FSHD versus unaffected and in FSHD with short versus long telomeres. We found that DUX4-target genes were slightly upregulated with differentiation in unaffected clones compared to FSHD clones with long telomeres (∆Cp of ~5, ~30 fold) and were dramatically more upregulated in FSHD clones with short telomeres (∆Cp of ~11, 2,000 fold). Plotting Cp values of each target gene as a function of DUX4 Cp gave linear correlations with R 2 values of 0.79-0.89 ( Supplementary  Fig. 5b) . In summary, we demonstrated that telomere shortening led to increased expression and transcriptional activity of DUX4-fl, highlighting its potential contribution to FSHD pathology.
Telomere shortening increases the fraction of DUX4-fl cells
Our data (Fig. 3) did not indicate whether telomere shortening increased the DUX4 levels per expressing cell or the fraction of expressing cells. The number of DUX4-fl-expressing nuclei in differentiating FSHD myoblasts is extremely low (1 in 1,000-2,000), as detected by antibody staining 13, 15 . The fraction of nuclei expressing DUX4-fl can be determined by what amounts to a fluctuation analysis using limiting numbers of nuclei 37 . We generated cDNA from multiple aliquots of 30-30,000 nuclei with long or short telomeres from an 01Adel subclone. Three PCR reactions from each aliquot were scored as either positive or negative (agarosegel images are shown in Supplementary Fig. 6 .) Zero, one, two or three positives denotes the number of positive RT-PCR reactions per triplicate for a given aliquot in Supplementary Table 2 . We modeled the number of DUX4 transcripts per cell with a zero-inflated Poisson distribution 38 embedded in a multilevel model that also accounts for stochastic subsampling from aliquots and stochastic RT-PCR detection. We found that the estimated fraction of cells expressing DUX4 was approximately ten-fold higher for short than for long telomeres (~1 in 200 versus ~1 in 2,000), whereas the estimated average transcript number for those cells that do express DUX4 remained roughly the same (Fig. 6) . We conclude that TPE thus behaved like an on-off switch in which increasing fractions of cells expressed DUX4-fl as telomeres shortened.
DISCUSSION
FSHD is a complex age-related disease whose molecular pathogenesis is poorly understood. We demonstrated that DUX4-fl, the primary known candidate for producing muscle toxicity, is regulated by telomere length in cultured myoblasts. FSHD is thus, to our knowledge, the first human disease demonstrating a potential contribution of classic TPE to the age-related phenotype.
Marked telomere shortening occurs in myoblasts between the neonatal and adult growth stages 39 . Our data showing that DUX4 expression progressively increased as telomeres shortened do not indicate a requirement for FSHD telomeres to be shorter than those from a r t i c l e s unaffected individuals. However, the pathological foci of degeneration and regeneration that are observed in FSHD suggest that satellitecell proliferation with an accompanying telomere shortening might be occurring. An attractive possibility is that myoblast proliferation causes telomere shortening, which increases DUX4-fl expression and increased toxicity in a positive feedback loop that contributes to disease progression. A central issue for determining the in vivo relevance of these in vitro results will be to determine the contribution of telomere length to the variable penetrance of FSHD that is frequently observed. There are a variety of theoretical and technical issues that need to be resolved before these data can be obtained. Average telomere length is highly variable in humans, and the average length is a complex sum of different lengths on different chromosome ends and different lengths on homologous paternally and maternally inherited chromosomes [40] [41] [42] . Much of the variability in the magnitude of TPE that we have observed in different lines could be explained by differences in telomere length of the specific chromosome 4q containing the contracted allele. Differences in the inherited telomere length of the contracted 4q allele could also contribute to the large variation in penetrance observed in FSHD.
It remains to be determined how closely the relative telomere length of the contracted 4q allele compares to average telomere length in myoblasts versus a more accessible cell population such as circulating lymphocytes. Our data indicate the importance of pursuing this information. Once the average telomere length is determined, in situ hybridization techniques using probes to D4Z4 repeats, telomeric repeats and subtelomeric regions of 4q and 10q should be able to quantify the relative signal intensity of the contracted 4q chromosome compared to the total telomeric signal from all chromosome ends and thus indicate whether the contracted allele is relatively long or short. If telomere length explains a significant part of the variance, it would have important clinical implications for counseling patients and their family members.
Yeast TPE extends only a few kilobases into the subtelomeric regions 19, 43 , and it was unknown how far TPE could extend in mammals. This study demonstrates that human TPE can influence gene expression at least 80 kb from the start of the telomeric repeats. This is a minimal value and will probably vary greatly between different chromosome ends, depending on what repressors, insulators and propagators are present.
Previous studies have shown a reduction in repressive chromatin marks and CpG methylation in the subtelomeric region in FSHDaffected compared to unaffected subjects 44 . This is consistent with the evolutionarily conserved role of cytidine methylation as a mechanism for recognizing and silencing repetitive sequences 45 . The presence of more than ten repeats could induce these subtelomeric modifications and prevent telomeric shortening from influencing gene expression in this region. The reduction in the number of D4Z4 repeats to <11 in FSHD could remove many of these modifications and make the region a r t i c l e s permissive for TPE. Differences in epigenetic modifications could also explain the differences in the magnitude of TPE we observed in different subclones from the same patient. The genetic signature for FSHD (shown in Fig. 1a ) has recently been shown to exist in 1% of the general population, which is two orders of magnitude higher than the prevalence of the disease 14 . This establishes that additional unknown factors contribute to this myopathy. Whether there are few or many remains to be determined. Our observations show that telomere length may be at least one of the contributing factors in this complex disease.
The increase in DUX4 expression when myoblasts differentiate that we and others have observed remains unexplained. DUX4 might be a developmental factor regulating the size of fetal muscles in the primate face and upper arms 13 . These very small primary fetal myofibers form the template for the adult musculature. Causing some of them to die might be a normal part of human development that modulates the size of particular adult muscles. The expression of DUX4 in some unaffected biopsies 15 and during differentiation of normal cell cultures by us and others 15, 46 would reflect a low-level expression of this normal developmental program (because expression in one nucleus of a fiber containing only three to four nuclei could easily cause death of the entire fiber rather than the complex focal degeneration seen in adult highly multinucleate muscle). The reduction in primary fibers would then lead to a reduction in the number of adult myofibers. This minor level of expression in normal cells would then be transformed into a major increase in FSHD as a result of the contractions and thus the reduction of the repressor-insulator function of the D4Z4 repeats.
In conclusion, we demonstrated, using isogenic clones with different telomere lengths, that the expression of the toxic homeodomain protein DUX4-fl is inversely regulated by telomere length. We compared affected and unaffected siblings from two families (as well as additional samples), eliminating the family effects that can confound studies of FSHD 29 . FSHD appears to be the first known example of a human disease in which classic TPE is able to affect molecular pathogenesis, as judged by its effects in cultured cells. Future studies will need to extend these observations in vivo. Variations in telomere length may contribute to the variable penetrance of this complex disease and may prove valuable in counseling of FSHD-affected patients and their families.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
ONLINE METHODS
Cell culture. Human myoblasts 28 were seeded in dishes coated with 0.1% pigskin gelatin (Sigma-Aldrich) in 4:1 DMEM/Medium 199 supplemented with 15% FBS, 0.02 M HEPES, 1.4 mg/l vitamin B12, 0.03 mg/l ZnSO 4 , 0.055 mg/l dexamethasone, 2.5 µg/l hepatocyte growth factor and 10 µg/l basic FGF. Cultures were passaged at ~50% confluency in 2-5% oxygen. Population doublings (PDs) were calculated as PD = ln[(final number of cells)/(initial number of cells)]/ln (2) . Cell strains used in this study are described in Supplementary Table 1 . GM17731 cells were from Coriell Cell Repository (Camden, New Jersey, USA). The 38/03 MDC1A myoblasts were kindly provided by P. Schneiderat (Muscle Tissue Culture Collection at the University of Munich, German network on muscular dystrophies, partner of EuroBioBank and TREAT-NMD).
For differentiation, cells seeded in growth medium were switched to differentiation medium (2% horse serum in 4:1 Dulbecco's modified Eagle's medium/ Medium 199) when 70-90% confluent.
Reversible immortalization. Primary human myoblasts prematurely undergo growth arrest in culture for unknown reasons unrelated to telomere length (for example, lack of an appropriate growth factor). We have shown that expression of CDK4 can bypass this premature growth arrest in myoblasts without affecting normal cell-cycle kinetics or the ability to differentiate normally 28, 47 . Primary cultures were transduced first with CDK4 to maintain CD56+ myogenic cells then with an excisable telomerase (Lox-TERT-hygromycin). Lox-TERT-hygromycin was excised by Cre recombinase, by transient transfection with pOG231 (ref. 48) or by stable integration of retroviral Cre. Excision of TERT-hygromycin was confirmed in clones by testing for hygromycin sensitivity and telomerase activity.
Terminal restriction fragment (TRF) assay. TRF assays were done as described 49 .
Quantitative real-time PCR. Cells were lysed (RNeasy Plus kit; Qiagen) after washing with PBS, scraped (scrapers from BD Biosciences) and sheared by centrifugation through Qiashredder columns (Qiagen). Total RNA purified according to the manufacturer's instructions was quantified on a Nanodrop 1000 spectrophotometer (Thermo Scientific). Total RNA (2 µg) was reverse transcribed in 20-µl reactions (Transcriptor first-strand cDNA synthesis kit, including random hexamers and oligo(dT) 18 primers; Roche). The cDNA was diluted 1:4 in water for qrt-PCR in triplicates (Lightcycler 480; Roche).
Supplementary Table 3 lists primers and PCR conditions. Melting curves were analyzed (SYBR green or EvaGreen assays) to exclude nonspecific amplification products. We confirmed amplicon size at least once on agarose gels. Crossingpoint (Cp) values were the second-derivative maxima. Cp values were normalized by subtracting the geometric means of three housekeeping genes (GAPDH, PPIA and HPRT1). All Cp values were corrected by their PCR efficiency, determined by 1:2 or 1:4 cDNA dilution series. Cp values were plotted on a reversed axis where a decreased Cp indicates increased mRNA.
High-throughput quantitative real-time PCR.
High-throughput qrt-PCR used the BioMark 96.96 Dynamic Array (Fluidigm) with TaqMan Gene Expression Assays (Applied Biosystems). cDNA (1.25 µl) was preamplified and assayed as described 29 Reporter assay. Myoblasts co-transfected with DUX4-promoter or FRG2promoter firefly luciferase constructs 9, 33 and an SV40-driven Renilla luciferase (Promega) by using PolyJet (SignaGen) were either harvested 48 h after transfection or after an additional 5 d in differentiation medium. Luciferase was measured by using the Dual-Luciferase Reporter Assay System (Promega) on an Optocomp I luminometer (MGM Instruments).
Statistical analysis.
Rates of DUX4 detection in qrt-PCR data were fit with a binomial mixed-effect model using R package lme4 (refs. 15,50) . Fixed effects were D4Z4 locus length (contracted or normal), telomere length (long or short), cell state (cycling or differentiated) and muscle type (biceps or deltoid), including all interactions between these. Random effects for qrt-PCR date and batch (each consisting of three technical replicates), days post differentiation and subject of origin accounted for these additional sources of variation. Each fixed-effect significance was computed by a likelihood ratio test of the full model versus one with the fixed effect deleted.
Determination of cell fraction expressing DUX4-fl in samples with limiting cell numbers. A multilevel probabilistic model calculated whether increased expression of DUX4 was from increased expression per cell or from a greater fraction of cells expressing DUX4. Differentiated cells were trypsinized and a nuclear aliquot taken (after centrifugation, the pellet was incubated in hypotonic solution (0.1M Na-citrate, pH 7.5, 2% Triton X-100 and 0.5% SDS for 5 min), vortexed and counted by hemacytometer with trypan blue). Remaining cells were centrifuged, washed (cold PBS), resuspended (cold PBS) and diluted to the desired concentration of nuclei. Aliquots (50 µl PBS) were added to 50 µl 2× lysis buffer (200 mM Tris-HCl, pH 7.5, 1 M LiCl, 20 mM EDTA, 2% LiDS and 10 mM DTT) and frozen (−80 °C). mRNA was isolated from individual aliquots by using Dynabeads mRNA Direct kit (Life Technologies), eluted by heat and reverse transcribed (oligo(dT) 18 primers, 25 µl, Transcriptor first-strand cDNA synthesis kit; Roche). A volume of 2 µl served as a template for DUX4fl 3′ PCR 13 in triplicates. Primers 182 for and 183 rev were nested with 1A for and 184 rev. Cycling conditions were as above, with decreased extension times (40 s first PCR, 30 s second PCR). Amplicons were run on 2% agarose gels, gelpurified and sequenced.
We used a multilevel probabilistic model that accounts for (i) variability in the number of copies of DUX4 in any aliquot, due to variability per cell; (ii) variability in the number of copies of DUX4 per replicate given the number per aliquot, due to stochastic multinomial sampling; and (iii) variability in whether DUX4 is detected in a replicate given the number of copies of DUX4 in the replicate, due to stochastic effects in PCR.
For (i), we used a zero-inflated Poisson (ZIP) model 38 for the number of copies of DUX4 per cell. This models a situation in which at the time of mRNA extraction, with probability β the number of DUX4 transcripts in a cell follows a Poisson distribution with mean λ, and with probability 1 -β the number of transcripts in a cell is zero. A cell from the Poisson component of this mixture may also have count zero (with probability e −λ ), so the overall distribution X for each cell is For (iii), we modeled the probability of detecting DUX4 in a replicate that initially has k i copies of DUX4 by Pr( | , ) ( ) d r k i i i k i = = = − − 1 1 1 g g , where the parameter γ represents the probability of detection when there is initially one copy of the transcript, and d i in {0,1} is an indicator variable for detection. To make the parameter estimates more robust to outliers, we included a 2% npg probability that detection will be random for any given replicate and a 2% probability that all three replicates from any given aliquot will take the same random value, so
